Inspirata Acquires GE's Omnyx, Expands Digital Pathology Portfolio

Jan 31, 2018

|

NEW YORK (360Dx) – Inspirata said today that it has acquired Pittsburgh-based Omnyx from GE Healthcare in a deal that will enable it to deliver an IVD device for primary diagnosis in Europe and Canada.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Inspirata Acquires GE's Omnyx, Expands Digital Pathology Portfolio

To read the full story....

Breaking News

CDC Reverses Position, Says Asymptomatic Patients Should Be Tested for SARS-CoV-2

Roche Nabs CE Mark for SARS-CoV-2 Quantitative Antibody Test

Foundation Medicine, Takeda Collaborate to Develop CDx for NSCLC Therapies

FDA Grants Emergency Use Authorization to Coronavirus Tests From Visby Medical, SNIBE

Mount Sinai Coronavirus Antibody Test Gets NYSDOH Emergency Use Authorization for Quantitative Use

In Brief This Week: Illumina, Siemens Healthineers, Danaher, Abbott, and More

What's Popular?

FDA Grants Emergency Use Authorization to Coronavirus Tests From Visby Medical, SNIBE

Qiagen Acquires Remaining Stake in NeuMoDx Molecular for $248M

Roche Gets FDA Emergency Use Authorization for Rapid Coronavirus, Flu Test

Cellex, Gauss Partner on At-Home, Point-of-Care Coronavirus Antigen Test

Fulgent Genetics Wins Utah COVID-19 Testing Contract

Sponsorships